Finance

Lists
4572:TYO
Carna Biosciences, Inc.
432,00 JP¥
-0,23%
(-1,00) 1D
30-сен., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4572...
Open
430 JP¥
High
433 JP¥
Low
409 JP¥
Mkt. cap
9,21 млд
Avg. vol.
151,94 миң
Volume
169,80 миң
52-wk high
512 JP¥
52-wk low
200 JP¥
EPS
-111 JP¥
Shares outstanding
10,14 млн
No. of employees
61
Open
430 JP¥
High
433 JP¥
Low
409 JP¥
Mkt. cap
9,21 млд
Avg. vol.
151,94 миң
Volume
169,80 миң
52-wk high
512 JP¥
52-wk low
200 JP¥
EPS
-111 JP¥
Shares outstanding
10,14 млн
No. of employees
61
About Carna Biosciences, Inc.
CEO-
Employees61
Founded2003-ж., 10-апр.
Headquarters-
SectorHealth care
Websitecarnabio.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
144,33 млн
183,57 млн
183,64 млн
217,36 млн
Cost of goods sold
47,38 млн
66,26 млн
52,35 млн
56,65 млн
Cost of revenue
47,38 млн
66,26 млн
52,35 млн
56,65 млн
Research and development expenses
-
1,85 млд
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
595,96 млн
-1,21 млд
589,72 млн
656,28 млн
Operating expense
595,96 млн
640,46 млн
589,72 млн
656,28 млн
Total operating expenses
643,35 млн
706,72 млн
642,07 млн
712,93 млн
Operating income
-499,01 млн
-523,14 млн
-458,44 млн
-495,56 млн
Other non operating income
-39,00 миң
-770,00 миң
369,00 миң
-11,37 млн
EBT including unusual items
-543,38 млн
-571,28 млн
-512,11 млн
-525,89 млн
EBT excluding unusual items
-535,04 млн
-555,94 млн
-488,97 млн
-517,03 млн
Income tax expense
572,00 миң
-287,00 миң
1,12 млн
-122,00 миң
Effective tax rate
-0,11%
0,05%
-0,22%
0,02%
Other operating expenses
-
-
-
-
Net income
-543,95 млн
-570,99 млн
-513,24 млн
-525,76 млн
Net profit margin
-376,88%
-311,05%
-279,49%
-241,88%
Earnings per share
-
-
-
-
Interest and investment income
993,00 миң
-
932,00 миң
1,07 млн
Interest expense
-33,90 млн
-17,72 млн
-13,19 млн
-20,81 млн
Net interest expenses
-32,91 млн
-17,72 млн
-12,25 млн
-19,75 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-491,20 млн
-515,40 млн
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору